PL3145508T3 - Nanocząstki klewidypiny i ich kompozycje farmaceutyczne - Google Patents
Nanocząstki klewidypiny i ich kompozycje farmaceutyczneInfo
- Publication number
- PL3145508T3 PL3145508T3 PL15795707.7T PL15795707T PL3145508T3 PL 3145508 T3 PL3145508 T3 PL 3145508T3 PL 15795707 T PL15795707 T PL 15795707T PL 3145508 T3 PL3145508 T3 PL 3145508T3
- Authority
- PL
- Poland
- Prior art keywords
- clevidipine
- nanoparticles
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- KPBZROQVTHLCDU-GOSISDBHSA-N clevidipine Chemical compound CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@H]1C1=CC=CC(Cl)=C1Cl KPBZROQVTHLCDU-GOSISDBHSA-N 0.000 title 1
- 229960003597 clevidipine Drugs 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462000119P | 2014-05-19 | 2014-05-19 | |
| PCT/US2015/031470 WO2015179334A1 (en) | 2014-05-19 | 2015-05-19 | Clevidipine nanoparticles and pharmaceutical compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3145508T3 true PL3145508T3 (pl) | 2023-10-23 |
Family
ID=54554604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15795707.7T PL3145508T3 (pl) | 2014-05-19 | 2015-05-19 | Nanocząstki klewidypiny i ich kompozycje farmaceutyczne |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11737989B2 (pl) |
| EP (1) | EP3145508B1 (pl) |
| KR (1) | KR102380701B1 (pl) |
| CN (2) | CN114668740A (pl) |
| CA (1) | CA2947486C (pl) |
| ES (1) | ES2950154T3 (pl) |
| MX (1) | MX385243B (pl) |
| PL (1) | PL3145508T3 (pl) |
| RU (1) | RU2759673C2 (pl) |
| WO (1) | WO2015179334A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105796494B (zh) * | 2016-04-01 | 2019-10-11 | 广东药科大学 | 一种含氨基酸的尼莫地平亚微乳注射液及其制备方法 |
| CN105796490B (zh) * | 2016-04-01 | 2019-12-10 | 广东药科大学 | 一种含氨基酸的尼莫地平注射液组合物及其制备方法 |
| CN107281104B (zh) * | 2017-05-27 | 2021-02-02 | 济南康和医药科技有限公司 | 一种丁酸氯维地平磷脂复合物脂质体及其制备方法 |
| EP3804703A1 (de) * | 2019-10-10 | 2021-04-14 | Bayer AG | Verfahren zur herstellung eines nanopartikulären wirkstoffs |
| EP3884930A1 (en) | 2020-03-23 | 2021-09-29 | Bayer AG | Nano-dry-melting |
| WO2024246613A1 (en) * | 2023-05-28 | 2024-12-05 | Precise Biopharma Pvt Ltd | A room temperature stable aqueous solution for injection of clevidipine |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453523A (en) * | 1993-06-16 | 1995-09-26 | Emulsion Technology, Inc. | Process for obtaining highly purified phosphatidylcholine |
| SE9303657D0 (sv) | 1993-11-05 | 1993-11-05 | Astra Ab | Short-acting dihydropyridines |
| SE9303744D0 (sv) | 1993-11-12 | 1993-11-12 | Astra Ab | Pharmaceutical emulsion |
| SE9804002D0 (sv) | 1998-11-23 | 1998-11-23 | Astra Ab | New manufacturing process |
| JP2009536162A (ja) * | 2006-05-04 | 2009-10-08 | ユニバーシティー オブ サウス オーストラリア | ナノ粒子被覆カプセルからの薬物放出 |
| EP2320740B1 (en) * | 2008-08-01 | 2014-03-26 | The Medicines Company | Pharmaceutical compositions of clevidipine and methods for producing low impurity concentrations of the same |
| US8679344B2 (en) * | 2008-12-17 | 2014-03-25 | Cerion Technology, Inc. | Process for solvent shifting a nanoparticle dispersion |
| DE102009008478A1 (de) | 2009-02-11 | 2010-08-19 | PHAST Gesellschaft für pharmazeutische Qualitätsstandards mbH | Vorrichtung und Verfahren zur Herstellung pharmazeutisch hochfeiner Partikel sowie zur Beschichtung solcher Partikel in Mikroreaktoren |
| KR101823706B1 (ko) * | 2010-03-22 | 2018-01-30 | 인스틸로 게엠베하 | 마이크로입자 또는 나노입자의 제조 방법 및 제조 장치 |
| GB201015079D0 (en) | 2010-09-10 | 2010-10-27 | Helperby Therapeutics Ltd | Novel use |
| US8658676B2 (en) * | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
| DK2627173T4 (en) * | 2010-10-12 | 2018-10-22 | Chiesi Farm Spa | CLEVIDIPINE EMULSUM FORMULATIONS CONTAINING ANTIMICROBIANTS |
| WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
| EP2526926A1 (de) * | 2011-05-25 | 2012-11-28 | Justus-Liebig-Universität Gießen | Biokompatible Nanopolymerpartikel mit Wirkstoffen für die pulmonale Applikation |
| US9446032B2 (en) | 2011-08-26 | 2016-09-20 | Wockhardt Limited | Methods for treating cardiovascular disorders |
| CA2925687A1 (en) * | 2012-09-27 | 2014-04-03 | The University Of North Carolina At Chapel Hill | Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof |
| EP2925128B1 (en) * | 2012-10-26 | 2018-04-11 | Chiesi Farmaceutici S.p.A. | Methods for controlling blood pressure and reducing dyspnea in heart failure |
| CN103479577A (zh) * | 2013-09-30 | 2014-01-01 | 山东大学 | 含有丁酸氯维地平的脂质纳米混悬剂及其冻干制剂 |
-
2015
- 2015-05-19 ES ES15795707T patent/ES2950154T3/es active Active
- 2015-05-19 CN CN202210357146.6A patent/CN114668740A/zh active Pending
- 2015-05-19 RU RU2016149538A patent/RU2759673C2/ru not_active Application Discontinuation
- 2015-05-19 WO PCT/US2015/031470 patent/WO2015179334A1/en not_active Ceased
- 2015-05-19 KR KR1020167032347A patent/KR102380701B1/ko active Active
- 2015-05-19 CA CA2947486A patent/CA2947486C/en active Active
- 2015-05-19 PL PL15795707.7T patent/PL3145508T3/pl unknown
- 2015-05-19 EP EP15795707.7A patent/EP3145508B1/en active Active
- 2015-05-19 US US15/312,461 patent/US11737989B2/en active Active
- 2015-05-19 MX MX2016015208A patent/MX385243B/es unknown
- 2015-05-19 CN CN201580033837.9A patent/CN106456617A/zh active Pending
-
2022
- 2022-11-29 US US18/071,110 patent/US12383507B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2947486A1 (en) | 2015-11-26 |
| WO2015179334A1 (en) | 2015-11-26 |
| RU2016149538A (ru) | 2018-06-20 |
| ES2950154T3 (es) | 2023-10-05 |
| US11737989B2 (en) | 2023-08-29 |
| EP3145508B1 (en) | 2023-07-05 |
| EP3145508A4 (en) | 2018-01-24 |
| BR112016027104A2 (pt) | 2018-07-10 |
| US20230145206A1 (en) | 2023-05-11 |
| RU2759673C2 (ru) | 2021-11-16 |
| KR20170032886A (ko) | 2017-03-23 |
| KR102380701B1 (ko) | 2022-03-31 |
| EP3145508C0 (en) | 2023-07-05 |
| US20170087093A1 (en) | 2017-03-30 |
| MX385243B (es) | 2025-03-14 |
| CA2947486C (en) | 2023-09-26 |
| MX2016015208A (es) | 2017-03-23 |
| CN114668740A (zh) | 2022-06-28 |
| RU2016149538A3 (pl) | 2019-01-17 |
| EP3145508A1 (en) | 2017-03-29 |
| CN106456617A (zh) | 2017-02-22 |
| US12383507B2 (en) | 2025-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR21C1059I2 (fr) | Compositions pharmaceutiques | |
| DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| PL3426348T3 (pl) | Pochodna 3-dezoksylowa i jej kompozycje farmaceutyczne | |
| MA50541A (fr) | Formulations pharmaceutiques | |
| MA42303A (fr) | Formulations pharmaceutiques | |
| DK3199161T3 (da) | Farmaceutisk præparat | |
| EP3316685A4 (en) | Lyophilized Pharmaceutical Compositions | |
| DK3191085T3 (da) | Misbrugsresistente farmaceutiske sammensætninger | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| PL3145508T3 (pl) | Nanocząstki klewidypiny i ich kompozycje farmaceutyczne | |
| ZA201607919B (en) | Dipicolylamine derivatives and their pharmaceutical uses | |
| EP3349788A4 (en) | Antimalarial Compositions and Methods | |
| EP3337463A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
| SG10202106375UA (en) | Pharmaceutical compositions and use thereof | |
| DK3288933T3 (da) | Oxindolforbindelser og farmaceutiske sammensætninger deraf | |
| SI3236952T1 (sl) | Farmacevtski sestavek v obliki tablet | |
| DK3166960T3 (da) | Lav-substituerede polymyxiner og sammensætninger deraf | |
| IL254711B (en) | History of diazepine-indole and medicinal preparations containing them | |
| PL3236938T3 (pl) | Doustne miejscowe wodne kompozycje farmaceutyczne flurbiprofenu i dekspantenolu | |
| DK3240529T3 (da) | Stabile farmaceutiske sammensætninger omfattende micafungin | |
| DK3089740T3 (da) | Farmaceutisk sammensætning | |
| EP3423041A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP3528818A4 (en) | PHARMACEUTICAL COMPOSITIONS |